The Health Tech company eyes the marketing partnership as key to accelerating its unicorn status.
Founder of GenepreDX, Dr. Hernán Gozalez, announced a marketing partnership with PJ Media. GeneproDX plans to engage PJ Media’s 360° marketing solutions, with a focus on brand awareness, digital media, and collaborating on education campaigns about GeneproDX’s patented product, ThyroidPrint.
ThyroidPrint is widely used by doctors in Latin America with plans for expansion to the U.S. and Europe in 2022. ThyroidPrint provides a highly-accurate diagnosis of thyroid nodules, resulting in fewer unnecessary surgeries — saving patients from life-altering surgical outcomes.
Creative Director of PJ Media, Philip Beere, has a unique understanding of the ThyroidPrint technology, due to his personal experience of incorrect diagnosis and improper treatment of his thyroid nodule in 2013. The experience inspired his podcast, Doctor Thyroid; 100+ episodes where he interviews the world’s leading thyroid doctors, as a means to help other patients avoid unnecessary surgeries and make better health decisions.
We are honored to be selected by GeneproDX as their marketing partner. Based on our work in the healthcare industry, thyroid-related specifically, the partnership is a natural fit. ThroidPrint is invaluable to patients and will help them make better decisions about their health.
PJ Media’s marketing solutions for healthcare professionals include Doctor Marketing and RFAMD, representing doctor clients globally.
About PJ Media
Are you overwhelmed with marketing? Are you looking for a brand refresh or an innovative marketing campaign? Or, are you simply needing help with a video, LinkedIn, or event production?
We can help you.
We work with thought-leaders and innovators — who want to take their brand to the next level with creative, content campaigns, and digital marketing.
About GeneproDX
GeneproDX is transforming traditional medicine —bridging Health Tech and AI and providing patients with fast, reliable, and accurate diagnostics. GeneproDX’s patented product, ThyroidPrint, is widely used by doctors in Latin America with plans for expansion to the U.S. and Europe in 2022. ThyroidPrint provides highly-accurate diagnosis, resulting in fewer unnecessary surgeries — saving patients from life-altering surgical outcomes.